Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib

Lars Henrik Jensen; Caroline Emilie Brenner Thomsen; René K Olesen; Anders Kindberg Boysen; Torben Frøstrup Hansen; Lise Nottelmann; Birgitte Mayland Havelund; Rikke Fredslund Andersen; Anders Jakobsen

doi:10.1200/jco.2018.36.15_suppl.e15541

Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib

Lars Henrik Jensen, Caroline Emilie Brenner Thomsen, René K Olesen, Anders Kindberg Boysen, Torben Frøstrup Hansen, Lise Nottelmann, Birgitte Mayland Havelund, Rikke Fredslund Andersen, Anders Jakobsen

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	e15541
Tidsskrift	Journal of Clinical Oncology
Vol/bind	36
Udgave nummer	15 Supplement
ISSN	0732-183X
DOI	https://doi.org/10.1200/jco.2018.36.15_suppl.e15541
Status	Udgivet - 2018

Dokumenter og links

10.1200/jco.2018.36.15_suppl.e15541

Citationsformater

Jensen, L. H., Brenner Thomsen, C. E., Olesen, R. K., Boysen, A. K., Hansen, T. F., Nottelmann, L., Havelund, B. M., Fredslund Andersen, R., & Jakobsen, A. (2018). Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib. Journal of Clinical Oncology, 36(15 Supplement), [e15541]. https://doi.org/10.1200/jco.2018.36.15_suppl.e15541

@article{4298fdf9bae7416e885cce41e373ffde,

title = "Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib",

author = "Jensen, {Lars Henrik} and {Brenner Thomsen}, {Caroline Emilie} and Olesen, {Ren{\'e} K} and Boysen, {Anders Kindberg} and Hansen, {Torben Fr{\o}strup} and Lise Nottelmann and Havelund, {Birgitte Mayland} and {Fredslund Andersen}, Rikke and Anders Jakobsen",

year = "2018",

doi = "10.1200/jco.2018.36.15_suppl.e15541",

language = "English",

volume = "36",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15 Supplement",

}

Jensen, LH, Brenner Thomsen, CE, Olesen, RK, Boysen, AK, Hansen, TF, Nottelmann, L, Havelund, BM, Fredslund Andersen, R & Jakobsen, A 2018, 'Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib', Journal of Clinical Oncology, bind 36, nr. 15 Supplement, e15541. https://doi.org/10.1200/jco.2018.36.15_suppl.e15541

Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib. / Jensen, Lars Henrik; Brenner Thomsen, Caroline Emilie; Olesen, René K et al.

I: Journal of Clinical Oncology, Bind 36, Nr. 15 Supplement, e15541, 2018.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib

AU - Jensen, Lars Henrik

AU - Brenner Thomsen, Caroline Emilie

AU - Olesen, René K

AU - Boysen, Anders Kindberg

AU - Hansen, Torben Frøstrup

AU - Nottelmann, Lise

AU - Havelund, Birgitte Mayland

AU - Fredslund Andersen, Rikke

AU - Jakobsen, Anders

PY - 2018

Y1 - 2018

U2 - 10.1200/jco.2018.36.15_suppl.e15541

DO - 10.1200/jco.2018.36.15_suppl.e15541

M3 - Conference abstract in journal

VL - 36

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15 Supplement

M1 - e15541

ER -